[Fingolimod treatment in multiple sclerosis].

  • Masami Tanaka
  • Published 2014 in
    Nihon rinsho. Japanese journal of clinical…


Multiple sclerosis (MS), an inflammatory disorder of the central nervous system, is characterized by relapsing-remitting (RR) clinical course. Fingolimod was the first oral therapy to prevent relapses in patients with RRMS, approved in Japan in 2011. In lymph node, fingolimod acts as functional antagonist, leading to internalization of sphingosine-1… (More)


Cite this paper

@article{Tanaka2014FingolimodTI, title={[Fingolimod treatment in multiple sclerosis].}, author={Masami Tanaka}, journal={Nihon rinsho. Japanese journal of clinical medicine}, year={2014}, volume={72 11}, pages={2010-4} }